Journals / Bezmiâlem Science / 2021 / Cilt: 9 - Sayı: 1

COVID-19 and Influenza Coexistence

COVİD-19 ve İnfluenza Birlikteliği

Pages
1–3
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further research is needed inthis area.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Viral pneumonia cases occur quite frequently in thecommunity.
📊
Key Findings & Data:The rate of viral infections in community-acquiredpneumonia is about 25%. severe acute respiratory syndromecoronavirus-2 (SARS-CoV-2) and influenza are also viruses that cancause pneumonia.
💡
Conclusion & Impact:Further research is needed inthis area.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Viral pneumonia cases occur quite frequently in thecommunity. The rate of viral infections in community-acquiredpneumonia is about 25%. severe acute respiratory syndromecoronavirus-2 (SARS-CoV-2) and influenza are also viruses that cancause pneumonia. In this study, we aimed to determine the rateof influenza co-infection in Coronavirus disease-19 (COVID-19)cases.Methods: The data of adult patients who applied to BezmialemVakıf University Hospital between March 6, 2020, and May 21,2020, which were positive with the SARS-CoV-2 polymerase chainreaction (PCR) test and influenza antigen test were retrospectivelyscanned from the hospital automation system.Results: SARS-CoV-2 PCR test was found positive in 498 adultpatients who applied to our hospital. Two hundrend-sixty ofthese patients were hospitalized and 238 were followed up on anoutpatient basis. In 88 patients SARS-CoV-2 PCR and influenzaantigen were studied, and 6 of them had positive influenza antigen.COVID-19 and influenza co-infection was not detected.Conclusion: In order to determine the exact rate of influenza andCOVID-19 co-infection, it is necessary to evaluate the patients whoapplied with the appropriate clinical picture from the beginning ofthe seasonal influenza period by using reverse transcription-PCR forthese two viral infections, if possible. Further research is needed inthis area.

Özet

Amaç: Viral pnömoniler toplumda oldukça sık görülür. Toplum kökenli pnömonide viral enfeksiyonların oranı yaklaşık %25’tir. Şiddetli akut solunum yolu enfeksiyonu-2 (SARS-CoV-2) ve influenza da pnömoniye neden olabilen virüslerdendir. Bu çalışmada Koronavirüs hastalığı-19 (COVİD-19) olgularında influenza koenfeksiyonu oranını belirlemeyi amaçladık. Yöntemler: 6 Mart 2020-21 Mayıs 2020 tarihleri arasında Bezmialem Vakıf Üniversitesi Hastanesi’ne başvuran, SARS-CoV-2 polimeraz zincir reaksiyonu (PZR) testi ve influenza antijen testi pozitif olarak sonuçlanan erişkin hastaların verileri retrospektif olarak hastane otomasyon sisteminden tarandı. Bulgular: Hastanemize başvurmuş olan erişkin hastaların 498’inde SARS-CoV-2 PZR testi pozitif bulundu. Bu hastaların 260’ı hastaneye yatırılarak, 238’i ayaktan takip edilen hastalardı. SARS-CoV-2 PZR ve influenza antijeni çalışılmış olan toplam 88 hasta mevcuttu ve bunların 45’inde influenza antijeni pozitifti. COVİD-19 ve influenza ko-infeksiyonu saptanmadı. Sonuç: İnfluenza ve COVİD-19 ko-enfeksiyonu oranını tam olarak belirlemek için mevsimsel influenza döneminin başından itibaren uygun klinik tablo ile başvuran hastaları bu iki viral enfeksiyon yönünden mümkünse gerçek zamanlı-PZR ile değerlendirmek gereklidir. Bu alanda daha fazla çalışmaya ihtiyaç vardır.

🔖

Cite This Article

KAÇMAZ, A. B., KOÇ, M. M., SÜMBÜL, B., OKAY, G., DURDU, B., AKKOYUNLU, Y., BÖLÜKÇÜ, S., ERSÖZ, A. B. U., ANDIÇ, N., KARAKUŞ, D. (2022). COVID-19 and Influenza Coexistence. Bezmiâlem Science, Cilt: 9 - Sayı: 1, 1–3. https://ajindex.com/articles/464001

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Burk M, El-Kersh K, Saad M, Wiemken T, Ramirez J, Cavallazzi R. Viral infection in community-acquired pneumonia: A systematic review and meta-analysis. Eur Respir Rev 2016;25:178-88
  2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20
  3. Cavallazzi R, Ramirez JA. Influenza and viral pneumonia. Clin Chest Med 2018;39:703-21
  4. Meşe S, Uyanik A, Özakay A, Öztürk S, Badur S. Influenza surveillance in western Turkey in the era of quadrivalent vaccines: A 2003-2016 retrospective analysis. Hum Vaccin Immunother 2018;14:1899-908
  5. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): A clinical update. Front Med 2020;14:126-35
  6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20
  7. Hasöksüz M, Kiliç S, Saraç F. Coronaviruses and SARS-COV-2. Turk J Med Sci 2020;50:549-56
  8. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 2020;323:2085-6
  9. Cuadrado-Payán E, Montagud-Marrahi E, Torres-Elorza M, Bodro M, Blasco M, Poch E, et al. SARS-CoV-2 and influenza virus coinfection. Lancet 2020;395:84
  10. Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 2020;92:1549-55
  11. Labella AM, Merel SE. Influenza. Med Clin North Am 2013;97:621- 45
  12. Wikramaratna PS, Gupta S. Influenza outbreaks. Cell Microbiol 2009;11:1016-24
  13. WHO. Coronavirus disease (COVID-19) Situation Report -159. Available from: https://www.who.int/docs/default-source/ coronaviruse/situation-reports/20200627-covid-19-sitrep-159. pdf?sfvrsn=93e027f6_2. Accessed 27 June 2020
  14. Yoo SJ, Shim HS, Yoon S, Moon HW. Evaluation of high-throughput digital lateral flow immunoassays for the detection of influenza A/B viruses from clinical swab samples. J Med Virol 2020;92:1040-6
  15. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934-43
  16. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA 2020;323:1612-4
  17. Lansbury L, Lim B,